New daily persistent @entity10 : A lack of an association with XXXX on neuroimaging.

@entity1 @entity2704 @entity1188 @entity62 @entity10
OBJECTIVE: To provide results from the largest study of new daily persistent @entity10 @entity1 to date and specifically evaluate if @entity1 with primary new daily persistent @entity10 develop @entity62 or @entity1188 on neuroimaging. METHODS: Retrospective analysis of @entity1 medical records utilizing an electronic medical record system. All @entity1 were seen at a @entity10 specialty clinic by a single @entity10 neurologist and diagnosed with primary new daily persistent @entity10 during the time period of January 2009 to January 2013. RESULTS: Altogether, 97 @entity1 were diagnosed with primary new daily persistent @entity10 (65 @entity1 and 32 @entity1 ). The mean average age of onset was slightly younger in @entity1 than @entity1 : 32.4 years vs. 35.8 years. In total, 84 of the 97 new daily persistent @entity10 @entity1 had no @entity62 or @entity1188 on magnetic resonance imaging with a gender distribution of 56 @entity1 and 28 @entity1 . The mean age of onset of this white matter negative subgroup was 31.1 years. Of these individuals, 36% had cardiovascular/cerebrovascular risk factors and 44% had a history of @entity2704 . Only 13 new daily persistent @entity10 @entity1 (nine @entity1 , four @entity1 ) demonstrated @entity62 on magnetic resonance imaging. None had @entity1188 . The mean age of onset of this white matter positive subgroup was 54.2 years, significantly older than the white matter negative population (p   <   .05). All new daily persistent @entity10 @entity1 in the white matter positive subgroup had cardiovascular/cerebrovascular risk factors and dual risk factors were noted in seven of 13 @entity1 . Only 23% had a @entity2704 history. Almost 40% of the @entity1 in the white matter negative group were imaged 3 years after @entity10 onset and at least six @entity1 were imaged at least 9 years or more after onset of new daily persistent @entity10 . Triggering events in both @entity62 positive and negative populations were typical of the new daily persistent @entity10 population as a whole and not specific to the presence or absence of brain imaging lesions except for a post-surgery trigger, which was significantly more likely to occur in the white matter positive group. @entity2704 associated symptoms occurred in 77% of the white matter negative subgroup compared with 46% of the white matter positive subgroup, which was a significant difference. CONCLUSION: @entity62 and @entity1188 do not appear to occur in primary new daily persistent @entity10 @entity1 . Only new daily persistent @entity10 @entity1 with risk factors (cardiovascular/cerebrovascular or @entity2704 ) developed @entity62 on brain magnetic resonance imaging. No @entity1 with new daily persistent @entity10 developed @entity1188 . New daily persistent @entity10 triggering events (outside of possibly post-surgery) or the presence of @entity2704 did not appear to enhance the development of @entity62 .
